GUANGDONG RAFFLES PHARMATECH CO LTD

Overview

GUANGDONG RAFFLES PHARMATECH CO LTD is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering (5R)-5-(2,2-DIMETHYL-4H-1,3-BENZODIOXIN-6-YL)-1,3-OXAZOLIDIN-2-ONE (VILANTEROL OXAZOLIDINONE INTERMEDIATE); DABRAFENIB MESYLATE; ELTROMBOPAG OLAMINE.

Core services & business areas

Active pharmaceutical ingredients supplied

Substances GUANGDONG RAFFLES PHARMATECH CO LTD is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

GUANGDONG RAFFLES PHARMATECH CO LTD holds 5 active (5 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• 2-{[(1R)-1-[5-(3-METHYL-1,2,4-THIADIAZOL-5-YL)-1,3,4-OXADIAZOL2-YL]LETHYL]AMINO}ETHAN-1-AMINE DIHYDROCHLORIDEActive2026-05-01
• ETHYL[(3R)-7-({[4-CYCLOPENTYL-3-(TRIFLUOROMETHYL)PHENYL]METHYL}OXY)-1,2,3,4-TETRAHYDROCYCLOPENTA[1,2-B]INDOL-3-YL]ACETATEActive2026-04-30
• DABRAFENIB MESYLATEActive2025-12-31
• ELTROMBOPAG OLAMINEActive2023-09-27
• (5R)-5-(2,2-DIMETHYL-4H-1,3-BENZODIOXIN-6-YL)-1,3-OXAZOLIDIN-2-ONE (VILANTEROL OXAZOLIDINONE INTERMEDIATE)Active2020-07-06

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to GUANGDONG RAFFLES PHARMATECH CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.